Logo image of COP.DE

COMPUGROUP MEDICAL SE & CO K (COP.DE) Stock Analyst Earnings Estimates

FRA:COP - Deutsche Boerse Ag - DE000A288904 - Common Stock - Currency: EUR

22.92  +0.08 (+0.35%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
COP.DE revenue by date.COP.DE revenue by date.
1.025B
22.46%
1.13B
10.18%
1.188B
5.13%
1.173B
-1.23%
1.204B
2.64%
1.241B
3.07%
1.252B
0.89%
1.298B
3.67%
1.523B
17.33%
1.582B
3.87%
EBITDA
YoY % growth
COP.DE ebitda by date.COP.DE ebitda by date.
211.462M
7.76%
216.162M
2.22%
227.561M
5.27%
232.32M
2.09%
248.83M
7.11%
263.31M
5.82%
267.27M
1.50%
276.96M
3.63%
N/AN/A
EBIT
YoY % growth
COP.DE ebit by date.COP.DE ebit by date.
100.749M
-16.41%
103.841M
3.07%
111.763M
7.63%
136.63M
22.25%
142.32M
4.16%
157.42M
10.61%
212.24M
34.82%
121.52M
-42.74%
260.21M
114.13%
285.45M
9.70%
Operating Margin
COP.DE operating margin by date.COP.DE operating margin by date.
9.83%9.19%9.41%11.65%11.82%12.68%16.95%9.36%17.09%18.04%
EPS
YoY % growth
COP.DE eps by date.COP.DE eps by date.
N/A
-13.68%
N/A
-9.01%
N/A
25.22%
1.63
-26.11%
1.65
1.38%
1.79
8.53%
N/AN/AN/AN/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
0.56 0.69-0.13-18.46%
Q2 2023
Q2Q % growth
0.62
27.89%
0.580.047.69%
Q1 2023
Q2Q % growth
0.45
3.62%
0.400.0511.39%
Q3 2022
Q2Q % growth
0.51
-27.14%
0.460.0510.98%
Q2 2022
Q2Q % growth

12.74%
0.48%
Q1 2022
Q2Q % growth

31.61%
0.43%
Q4 2021
Q2Q % growth

9.78%
0.51%
Q3 2021
Q2Q % growth
0.70
-1.41%
0.550.1528.35%
Q2 2021
Q2Q % growth
0.43
13.16%
0.190.24124.08%
Q1 2021
Q2Q % growth
0.33 0.220.1148.51%
Q4 2020
Q2Q % growth
0.46
-26.98%
2.35-1.89-80.45%
Q3 2020
Q2Q % growth
0.71
39.22%
0.620.0915.24%
Q2 2020
Q2Q % growth
0.38
-35.59%
%
Q4 2019
Q2Q % growth
0.63 0.400.2355.94%
Q3 2019
Q2Q % growth
0.51 0.260.2594.21%
Q2 2019
Q2Q % growth
0.59 0.440.1532.76%
Q1 2019
Q2Q % growth
0.61 0.450.1634.96%
COP.DE Yearly EPS VS EstimatesCOP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
283.444M
-0.80%
%
Q2 2024
Q2Q % growth
277.229M
-8.86%
%
Q1 2024
Q2Q % growth
284.624M
-2.14%
%
Q4 2023
Q2Q % growth
306.924M
-6.33%
310.61M-3.686M-1.19%
Q3 2023
Q2Q % growth
285.718M
0.12%
%
Q2 2023
Q2Q % growth
304.179M
14.76%
306.21M-2.031M-0.66%
Q1 2023
Q2Q % growth
290.843M
15.57%
282.62M8.223M2.91%
Q4 2022
Q2Q % growth
327.656M
17.35%
%
Q3 2022
Q2Q % growth
285.387M
3.27%
278.66M6.727M2.41%
Q2 2022
Q2Q % growth
265.047M
10.06%
257.55M7.497M2.91%
Q1 2022
Q2Q % growth
251.649M
9.92%
262.6M-10.951M-4.17%
Q4 2021
Q2Q % growth
279.213M
14.95%
283.91M-4.697M-1.65%
Q3 2021
Q2Q % growth
276.344M
19.46%
274.48M1.864M0.68%
Q2 2021
Q2Q % growth
240.827M
33.88%
237.55M3.277M1.38%
Q1 2021
Q2Q % growth
228.937M
25.00%
236.85M-7.913M-3.34%
Q4 2020
Q2Q % growth
242.91M
17.87%
249.62M-6.71M-2.69%
Q3 2020
Q2Q % growth
231.325M
30.02%
225.01M6.315M2.81%
Q2 2020
Q2Q % growth
179.88M
-3.60%
183.52M-3.64M-1.98%
Q1 2020
Q2Q % growth
183.143M
4.53%
%
Q4 2019
Q2Q % growth
206.084M 190.12M15.964M8.40%
Q3 2019
Q2Q % growth
177.918M 171.13M6.788M3.97%
Q2 2019
Q2Q % growth
186.592M 190.65M-4.058M-2.13%
Q1 2019
Q2Q % growth
175.214M 172.91M2.304M1.33%
COP.DE Yearly Revenue VS EstimatesCOP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 2.68% 2.68%
RevenueN/A N/A -0.42% -0.42%